Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Receives Average Recommendation of “Hold” from Analysts

Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY) have been assigned a consensus rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company.

A number of analysts have weighed in on CZMWY shares. Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. The Goldman Sachs Group downgraded shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 20th.

Carl Zeiss Meditec Stock Up 2.9%

Shares of CZMWY opened at $27.49 on Tuesday. The stock has a 50 day moving average price of $33.72 and a 200 day moving average price of $44.51. Carl Zeiss Meditec has a 52-week low of $26.65 and a 52-week high of $76.25.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.